Dow Jones Futures Eye Geopolitical Cues as Trump Signals No Rush for Iran Deal Tesla AI Stocks Attract Attention
Indian Equity Markets Wobble as Key Stocks See Mixed Activity
NTPC Q4 Net Profit Rises 34 to 10615 Crore Revenue Slips to 5041058 Crore
Hormel Foods Considered Among Top HighYield Stocks for Retirement Portfolios
Expert View Buy on Dips Strategy May Be Avoided Amid Market Volatility Says HDFC Securities Analyst
Zscaler Stock Tumbles on Weak Guidance Sales Reorganization
UTMD Q1 2024 Earnings Solid EPS Performance Amidst Cautious Market Reaction
HDB Q1 FY2026 Earnings EPS Surpasses Estimates by 073
SPOK Q1 2026 Earnings EPS Misses Estimates by 51 Revenue Data Unavailable
WPRT Q1 2026 Earnings BetterthanExpected EPS but Stock Declines
APPN Q1 2026 Earnings EPS Surge Beats Estimates by 44
WRB Q1 2026 Earnings Strong EPS Beat Driven by Solid Underwriting and Investment Results
Futu Holdings FUTU Slumps 275 as Key Support Levels Come Into Focus
Ambiq Micro AMBQ Shows Resilience with 186 Gain as Stock Holds Above Key Support
Aurinia Pharmaceuticals AUPH Treads at 1522 as Shares Dip Support and Resistance in Focus
First Merchants Corporation Depository Shares FRMEP Holds Steady at 2505 Key Levels in Focus
Atossa Therapeutics ATOS Holds Steady Near Support Amid Modest Decline
US Government Stake in Quantum Firms Traders Eye IonQ Micron Anduril as Next Candidates
ASPN Q1 2026 Earnings EPS Misses Estimates as Losses Narrow but Surprise Negative
Diversified Healthcare Trust 5625 Senior Notes 2042 DHCNI Hold Steady Near 1838 Following Modest Uptick
QuinStreet Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Gains
Core Main Inc CNM Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency
Penumbra PEN Q1 2026 Earnings EPS Misses Estimates by 245 as Revenue Details Remain Unclear
ING Q1 2026 Earnings EPS Beats Estimates by 66 as Net Interest Income Holds Steady Stock Declines
VOC Q3 2024 Earnings Trust Reports EPS of 018 Amid Stable Distributions
CDP Q1 2026 Earnings EPS Surpasses Estimates with 2 Beat
CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue